In the Matter of Certain Recombinantly Produced Hepatitis B Vaccines and Products Containing Same; Notice of Investigation

Résumé

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 3, 1998, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of Chiron Corporation, 4560 Horton Street Emeryville, California 94608. A supplementary letter and an amended complaint were filed on April 20, 1998. A second supplement was filed on April 27, 1998. The complaint, as amended and supplemented, alleges violations of section 337 in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain recombinantly produced Hepatitis B vaccines, and products containing same, made by processes that infringe claims 4, 5, 7, and 8 of U.S. Letters Patent Re. 35,749. The complaint further alleges that there exists an industry in the United States as required by subsection (a)(2) of section 337. The complainant requests that the Commission institute an investigation and, after a hearing, issue a permanent exclusion order and permanent cease and desist orders.